Home LiteratureArticle Details
PMID: 8083379 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Diet-induced atherosclerosis in mice heterozygous and homozygous for apolipoprotein E gene disruption.

The Journal of clinical investigation ·Vol. 94 ·No. 3 ·1994-09-00 ·Pages 937-45

Zhang SH, Reddick RL, Burkey B, Maeda N

Abstract

With the aim of establishing whether a genetically reduced capability of producing apolipoprotein E (apo E) can affect atherogenesis, we have compared the consequences of dietary stress on normal mice and on mice heterozygous or homozygous for a disrupted apo E gene. A dramatically accelerated development of lesions occurred in the vasculature of the homozygous mutants as a result of feeding an atherogenic diet for 12 wk, and extensive deposition of lipid-filled macrophages was found outside the cardiovascular system. In nine heterozygotes fed the atherogenic diet for 12 wk, the amount of apo E in their total plasma lipoproteins increased to a level comparable to normal, but all nine developed much larger foam cell lesions in their proximal aorta than those found in 3 of 9 normal mice fed the same diet. The other six normals had no lesions. Our study demonstrates that heterozygous mice with only one functional apo E gene are more susceptible to diet-induced atherosclerosis than are normal, two-copy mice. Genetically determined quantitative limitations of apo E could, therefore, have similar effects in humans when they are stressed by an atherogenic diet.

MeSH Terms
Animals Apolipoproteins E/genetics,metabolism Arteries/pathology Arteriosclerosis/blood,genetics,pathology Cholesterol/blood Cholesterol, HDL/blood Diet, Atherogenic Female Heterozygote Homozygote Lipoproteins/blood Liver/pathology,ultrastructure Macrophages/pathology Male Mice Mice, Inbred C57BL Mice, Inbred Strains Mice, Mutant Strains Muscle, Smooth, Vascular/pathology Reference Values Triglycerides/blood
Chemicals
Apolipoproteins E Cholesterol, HDL Lipoproteins Triglycerides Cholesterol
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Zhang S H
Department of Pathology, School of Medicine, University of North Carolina at Chapel Hill 27599-7525.
Reddick R L
Burkey B
Maeda N
References (30)
30 references, click to expand
  1. Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B, and cholesterol metabolism.
    Am J Hum Genet. 1988 Jan;42(1):104-12 PMID: 3337104
  2. Dependence of metabolic and structural heterogeneity of cholesterol ester-rich very low density lipoproteins on the duration of cholesterol feeding in rabbits.
    J Clin Invest. 1988 Aug;82(2):562-70 PMID: 3403717
  3. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.
    Arterioscler Thromb. 1994 Jan;14(1):133-40 PMID: 8274468
  4. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E.
    Science. 1992 Oct 16;258(5081):468-71 PMID: 1411543
  5. Lipoproteins and atherogenesis. Current concepts.
    JAMA. 1990 Dec 19;264(23):3047-52 PMID: 2243434
  6. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells.
    Cell. 1992 Oct 16;71(2):343-53 PMID: 1423598
  7. Apolipoprotein E deficiency with a depressed mRNA of normal size.
    Atherosclerosis. 1991 May;88(1):15-20 PMID: 1878006
  8. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery.
    J Clin Invest. 1993 Aug;92(2):883-93 PMID: 8349823
  9. Gene-environment interactions in atherosclerosis.
    Mol Cell Biochem. 1992 Aug 18;113(2):177-86 PMID: 1325605
  10. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol.
    Clin Chem. 1982 Jun;28(6):1379-88 PMID: 7074948
  11. Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression.
    Arterioscler Thromb. 1994 Jan;14(1):141-7 PMID: 8274470
  12. Abnormal low density lipoprotein metabolism in apolipoprotein E deficiency.
    J Lipid Res. 1986 Mar;27(3):326-33 PMID: 3734629
  13. Atherogenesis: a postprandial phenomenon.
    Circulation. 1979 Sep;60(3):473-85 PMID: 222498
  14. Effects of cholesterol and fat modification of self-selected diets on serum lipids and their specific fatty acids in normocholesterolemic and hypercholesterolemic humans.
    J Am Coll Nutr. 1991 Apr;10(2):93-106 PMID: 2030259
  15. A young type III hyperlipoproteinemic patient associated with apolipoprotein E deficiency.
    Metabolism. 1989 Feb;38(2):115-9 PMID: 2492364
  16. Apolipoprotein E polymorphisms affect atherosclerosis in young males. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group.
    Arterioscler Thromb. 1991 Sep-Oct;11(5):1237-44 PMID: 1680392
  17. Cholesterol-fed heterozygous Watanabe heritable hyperlipidemic rabbits: a new model for atherosclerosis.
    Atherosclerosis. 1989 Aug;78(2-3):123-36 PMID: 2783197
  18. Myocardial infarction in rats fed diets containing high fat, cholesterol, thiouracil, and sodium cholate.
    Circulation. 1959 Jan;19(1):65-72 PMID: 13619021
  19. Apolipoprotein E4 homozygosity predisposes to serum cholesterol elevation during high fat diet.
    Arteriosclerosis. 1990 Mar-Apr;10(2):285-8 PMID: 2317162
  20. Transgenic mouse models of lipoprotein metabolism and atherosclerosis.
    Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8314-8 PMID: 8378301
  21. Magnitude of dietary effects on plasma cholesterol concentration: role of sex and apolipoprotein E phenotype.
    Atherosclerosis. 1991 Feb;86(2-3):145-52 PMID: 1872909
  22. Effects of atherogenic diet consumption on lipoproteins in mouse strains C57BL/6 and C3H.
    J Lipid Res. 1991 Apr;32(4):559-68 PMID: 1856605
  23. Isolation and characterization of plasma lipoproteins of common marmoset monkey. Comparison of effects of control and atherogenic diets.
    Arteriosclerosis. 1990 Jul-Aug;10(4):633-47 PMID: 2114868
  24. Polymorphism at the apoprotein-E locus in relation to risk of coronary disease.
    Clin Genet. 1984 Apr;25(4):310-3 PMID: 6713705
  25. Relationship of an abnormal plasma lipoprotein to protection from atherosclerosis in the cholesterol-fed diabetic rabbit.
    J Clin Invest. 1983 Nov;72(5):1553-62 PMID: 6630518
  26. Structural and metabolic heterogeneity of beta-very low density lipoproteins from cholesterol-fed dogs and from humans with type III hyperlipoproteinemia.
    J Lipid Res. 1982 Jul;23(5):702-14 PMID: 7119569
  27. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.
    J Clin Invest. 1955 Sep;34(9):1345-53 PMID: 13252080
  28. Apolipoprotein E polymorphism influences the serum cholesterol response to dietary intervention.
    Metabolism. 1991 Feb;40(2):217-21 PMID: 1988781
  29. Serum cholesterol response to dietary cholesterol and apoprotein E phenotype.
    Lancet. 1988 Nov 26;2(8622):1261 PMID: 2903999
  30. Apolipoprotein E and lipoprotein lipase reduce macrophage degradation of oxidized very-low-density lipoprotein (VLDL), but increase cellular degradation of native VLDL.
    Metabolism. 1992 Nov;41(11):1185-92 PMID: 1435289
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1994-09-00
Pages
937-45
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC295131
Subset
IM
Grants
NHLBI NIH HHS · HL42630 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]